Search hospitals > New Mexico > Farmington

San Juan Oncology Associates

Claim this profile
Farmington, New Mexico 87401
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Multiple Myeloma
Conducts research for Cancer
60 reported clinical trials
3 medical researchers
Photo of San Juan Oncology Associates in FarmingtonPhoto of San Juan Oncology Associates in FarmingtonPhoto of San Juan Oncology Associates in Farmington

Summary

San Juan Oncology Associates is a medical facility located in Farmington, New Mexico. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma, Cancer and other specialties. San Juan Oncology Associates is involved with conducting 60 clinical trials across 94 conditions. There are 3 research doctors associated with this hospital, such as Sardar Imam, Sardar Z Imam, and Jeffrey Neidhart.

Area of expertise

1Lung Cancer
Global Leader
San Juan Oncology Associates has run 15 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
metastatic
Stage III
2Breast Cancer
Global Leader
San Juan Oncology Associates has run 12 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
ER positive

Top PIs

Clinical Trials running at San Juan Oncology Associates

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Stomach Cancer
Myelodysplastic Syndrome
Cancer
Multiple Myeloma
Breast cancer
Stomach Tumors
Gastric Cancer
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Disitamab Vedotin + Tucatinib

for Breast Cancer

This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV with tucatinib works for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 26 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at San Juan Oncology Associates?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security